Pharmaceuticals

Teva: Don’t Be so Generic

January 12, 2018 / by Sooruj Ghangass and Gordon Sun / 0 Comment

Gilead: Cultivating the Pipeline

April 24, 2017 / by Jason Cheung and Dennis Zhan / 0 Comment

In order to restore investor confidence and hedge legacy market downturns, Gilead needs to diversify into other channels of sustainable revenue generation to minimize volatility


0

The Biosimilar Onslaught

January 05, 2016 / by Kevin Shi and Nawid Sayed / 0 Comment

Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.

The Perfect Remedy

January 04, 2012 / by David Stewart and Sabriya Karim / 0 Comment

Could drug incubation allow Canada to better compete in the global pharmaceutical industry?

The Big Pharma Bust

April 03, 2010 / by Juthika Thakur / 0 Comment

The collapse of Western pharmaceutical companies is inevitable